Urolithin A
Targets mitochondrial quality
Urolithin A activates mitophagy, the selective recycling process that removes damaged mitochondria. Its human evidence is newer and more focused than the broad CoQ10 literature.
Evidence-led comparison

The short answer
CoQ10 is the more established choice for people specifically addressing low CoQ10 status, statin-associated concerns under clinical guidance, or fatigue, where meta-analyses report benefits across varied populations. Urolithin A is the more targeted choice for mitochondrial quality and muscle-aging priorities, particularly through mitophagy activation, selected human muscle outcomes, and consistent delivery independent of gut-microbiome conversion.
At a glance
The comparison is organized by biological role, evidence maturity, and the outcomes each ingredient is best positioned to support.
| Dimension | Urolithin A | CoQ10 | Bottom line |
|---|---|---|---|
| Primary role | Activates mitochondrial quality control through mitophagy | Transfers electrons in the respiratory chain and acts as an antioxidant | Renewal versus energy transfer |
| Best-established use | Selected mitochondrial, endurance, and strength outcomes | Fatigue reduction and contexts involving CoQ10 status | Evidence is outcome-specific |
| Direct mitochondrial action | Helps remove damaged mitochondria | Supports ATP production inside existing mitochondria | Different layers of mitochondrial function |
| Human evidence | Several randomized trials and a recent systematic review | Many trials across diverse healthy and clinical populations | CoQ10 evidence is broader but heterogeneous |
| Typical studied intake | 500–1,000 mg daily | Dose and formulation vary widely by study and indication | Formulation and context matter |
| Most relevant goal | Mitochondrial quality, muscle endurance, healthy aging | Fatigue, antioxidant support, or identified CoQ10 needs | Goal determines fit |
Mechanisms
Urolithin A
Urolithin A activates mitophagy, the selective recycling process that removes damaged mitochondria. Its human evidence is newer and more focused than the broad CoQ10 literature.
CoQ10
CoQ10 transfers electrons within the mitochondrial respiratory chain, helping drive ATP production. It also acts as an antioxidant in membranes and lipoproteins.
Human evidence
Urolithin A evidence
Trials reported improvements in selected strength or endurance measures and favorable biomarkers. Several primary functional endpoints did not significantly improve, and larger, longer studies are needed.
CoQ10 evidence
A 2022 meta-analysis of 13 randomized trials involving 1,126 participants found a significant reduction in fatigue scores. Exercise-performance findings remain inconsistent and population dependent.
Choosing by goal
Mitopure® is Amazentis’ proprietary, highly pure form of Urolithin A used in published human clinical studies. CoQ10 supports electron transfer and antioxidant function in existing mitochondria; Mitopure targets the quality-control process that identifies and recycles damaged mitochondria.
References
Common questions
Neither is universally better. CoQ10 has broader evidence across fatigue and several clinical contexts. Urolithin A is more specifically studied as a mitophagy activator for mitochondrial quality and selected muscle outcomes.
CoQ10 transfers electrons within the mitochondrial respiratory chain and acts as an antioxidant. Urolithin A activates mitophagy, helping cells identify and recycle damaged mitochondria.
CoQ10 products are often less expensive, but prices vary by dose and formulation. Cost alone is not a valid comparison because the compounds target different biological processes.
Urolithin A should not be treated as a direct replacement when a clinician has identified a specific CoQ10-related need. The choice depends on whether the priority is quality control or energy transfer and antioxidant function.
People focused on fatigue, diagnosed CoQ10 deficiency, or medication-related CoQ10 questions should discuss CoQ10 with a qualified clinician because the decision context differs from general healthy-aging supplementation.
Their mechanisms are distinct, but robust human trials have not shown that the combination produces additive benefits. Medication users should consult a healthcare professional before combining supplements.
